Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Leukemia, Myeloid, Acute 17Leukemia 11Myelodysplastic Syndromes 10Recurrence 8Lymphoma 8Burkitt Lymphoma 8Leukemia, Biphenotypic, Acute 7Multiple Myeloma 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Sarcoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4Hematologic Neoplasms 4Primary Myelofibrosis 3Neoplasms, Plasma Cell 3Leukemia, Myeloid 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2

Interventions

Methotrexate 1Cyclophosphamide 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Breast Cancer Female × Methotrexate × Clear all
NCT03518242 2022-06-08

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

Fred Hutchinson Cancer Center

Phase 1 Completed
100 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡